Marquette Asset Management’s Halozyme HALO Stock Holding History

Marquette Asset Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-25	Closed	-$1.83K	–	782
2025 Q3	$1.83K	Buy	+25	New	+$1.66K	﹤0.01%	564

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marquette Asset Management's HALO Position: Q4 2025 in Review

Marquette Asset Management sold out of Halozyme (HALO) in Q4 2025, closing a stake of 25 shares — an estimated $1.83K sold.

Marquette Asset Management first reported a position in HALO in Q3 2025 and held it in 1 quarter. The position peaked at $1.83K in Q3 2025. 617 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

Marquette Asset Management reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
Marquette Asset Management sold 25 Halozyme shares in Q4 2025, an estimated $1.83K.
Marquette Asset Management first reported a position in Halozyme in Q3 2025 and held it in 1 quarter.
Marquette Asset Management's Halozyme position peaked at $1.83K in Q3 2025.
617 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Marquette Asset Management's 13F filing for Q4 2025, filed 16 Jan 2026.